(Q43265559)

17 November 2017

Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

17 November 2017

1 reference

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

1 reference

John Willy Haukeland

1

1 reference

17 November 2017

Zbigniew Konopski

2

1 reference

17 November 2017

Heidi Beate Eggesbø

3

1 reference

17 November 2017

Hilde Løland von Volkmann

4

1 reference

17 November 2017

Gabriele Raschpichler

5

1 reference

17 November 2017

Kristian Bjøro

6

1 reference

17 November 2017

Terese Haaland

7

1 reference

17 November 2017

Else Marit Løberg

8

1 reference

17 November 2017

Kåre Birkeland

9

1 reference

17 November 2017

1 January 2009

1 reference

Scandinavian Journal of Gastroenterology

17 November 2017

1 reference

17 November 2017

44

1 reference

17 November 2017

853-860

1 reference

17 November 2017

7

1 reference

Nonalcoholic fatty liver disease

17 November 2017

1 reference

https://api.crossref.org/works/10.1080%2F00365520902845268

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902845268

Long-term follow-up of patients with NAFLD and elevated liver enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902845268

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902845268

Role of AMP-activated protein kinase in mechanism of metformin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902845268

Metformin reverses fatty liver disease in obese, leptin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902845268

Metformin in non-alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902845268

Metformin in the treatment of patients with non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902845268

Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902845268

Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902845268

Comparison of CT methods for determining the fat content of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902845268

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902845268

A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902845268

A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902845268

Non-alcoholic fatty liver disease and increased risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902845268

Metformin and body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902845268

Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902845268

Metformin: new understandings, new uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902845268

Leptin and liver tissue repair: do rodent models provide the answers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902845268

Histological progression of non-alcoholic fatty liver disease: a critical reassessment based on liver sampling variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902845268

10.1080/00365520902845268

21 January 2018

Identifiers

DOI

1 reference

17 November 2017

1 reference